Elias H. Sarkis, MD

Sarkis Clinical Trials

Disclosure(s): Abbvie: Grant/Research Support, Speakers Bureau; Eisai: Grant/Research Support; GlaxoSmithKline: Third party funding to Vir; Ironshore: Grant/Research Support; Janssen: Speakers Bureau; Lilly: Grant/Research Support; Otsuka: Grant/Research Support; Teva: Speakers Bureau; Vir Biotechnology Inc: Support as a trial site paid to my institution and non-financial support for medical writing support

Poster(s):

• 1150 - Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET